PortfoliosLab logoPortfoliosLab logo
BIO vs. DIS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BIO vs. DIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bio-Rad Laboratories, Inc. (BIO) and The Walt Disney Company (DIS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BIO achieves a 0.61% return, which is significantly higher than DIS's -12.64% return. Over the past 10 years, BIO has outperformed DIS with an annualized return of 7.47%, while DIS has yielded a comparatively lower 0.88% annualized return.


BIO

1D
-0.42%
1M
18.22%
YTD
0.61%
6M
-4.84%
1Y
38.20%
3Y*
-6.45%
5Y*
-12.11%
10Y*
7.47%

DIS

1D
-1.99%
1M
-1.90%
YTD
-12.64%
6M
-5.37%
1Y
-11.54%
3Y*
3.87%
5Y*
-10.50%
10Y*
0.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BIO vs. DIS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BIO
Bio-Rad Laboratories, Inc.
0.61%-7.77%1.74%-23.21%-44.35%29.61%57.54%59.34%-2.70%30.94%
DIS
The Walt Disney Company
-12.64%3.30%24.44%4.26%-43.91%-14.51%25.27%33.51%3.61%4.76%

Correlation

The correlation between BIO and DIS is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.32

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Feb 28, 1980

0.24

Fundamentals

Market Cap

BIO:

$8.22B

DIS:

$176.12B

EPS

BIO:

$6.24

DIS:

$6.25

PE Ratio

BIO:

48.81

DIS:

15.90

PEG Ratio

BIO:

0.45

DIS:

0.22

PS Ratio

BIO:

3.18

DIS:

1.83

PB Ratio

BIO:

1.20

DIS:

1.62

Total Revenue (TTM)

BIO:

$2.59B

DIS:

$97.26B

Gross Profit (TTM)

BIO:

$1.34B

DIS:

$36.14B

EBITDA (TTM)

BIO:

$746.20M

DIS:

$20.74B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIO vs. DIS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIO
BIO Risk / Return Rank: 6868
Overall Rank
BIO Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
BIO Sortino Ratio Rank: 6868
Sortino Ratio Rank
BIO Omega Ratio Rank: 6868
Omega Ratio Rank
BIO Calmar Ratio Rank: 6666
Calmar Ratio Rank
BIO Martin Ratio Rank: 6767
Martin Ratio Rank

DIS
DIS Risk / Return Rank: 2121
Overall Rank
DIS Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
DIS Sortino Ratio Rank: 1919
Sortino Ratio Rank
DIS Omega Ratio Rank: 1919
Omega Ratio Rank
DIS Calmar Ratio Rank: 2525
Calmar Ratio Rank
DIS Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIO vs. DIS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and The Walt Disney Company (DIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIODISDifference

Sharpe ratio

Return per unit of total volatility

0.94

-0.48

+1.41

Sortino ratio

Return per unit of downside risk

1.64

-0.53

+2.16

Omega ratio

Gain probability vs. loss probability

1.21

0.94

+0.28

Calmar ratio

Return relative to maximum drawdown

1.33

-0.46

+1.79

Martin ratio

Return relative to average drawdown

3.19

-0.96

+4.15

BIO vs. DIS - Sharpe Ratio Comparison

The current BIO Sharpe Ratio is 0.94, which is higher than the DIS Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of BIO and DIS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BIODISDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.94

-0.48

+1.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.33

-0.36

+0.03

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

0.03

+0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

0.27

0.34

-0.07

Drawdowns

BIO vs. DIS - Drawdown Comparison

The maximum BIO drawdown since its inception was -83.64%, roughly equal to the maximum DIS drawdown of -85.66%. Use the drawdown chart below to compare losses from any high point for BIO and DIS.


Loading charts...

Drawdown Indicators


BIODISDifference

Max Drawdown

Largest peak-to-trough decline

-83.64%

-85.66%

+2.02%

Max Drawdown (1Y)

Largest decline over 1 year

-28.86%

-24.97%

-3.89%

Max Drawdown (3Y)

Largest decline over 3 years

-48.76%

-32.86%

-15.90%

Max Drawdown (5Y)

Largest decline over 5 years

-73.77%

-57.33%

-16.44%

Max Drawdown (10Y)

Largest decline over 10 years

-73.77%

-60.72%

-13.05%

Current Drawdown

Current decline from peak

-63.09%

-49.62%

-13.47%

Average Drawdown

Average peak-to-trough decline

-27.73%

-26.77%

-0.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.00%

12.05%

-0.05%

Volatility

BIO vs. DIS - Volatility Comparison

Bio-Rad Laboratories, Inc. (BIO) has a higher volatility of 15.46% compared to The Walt Disney Company (DIS) at 9.87%. This indicates that BIO's price experiences larger fluctuations and is considered to be riskier than DIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BIODISDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.46%

9.87%

+5.59%

Volatility (6M)

Calculated over the trailing 6-month period

28.42%

19.46%

+8.96%

Volatility (1Y)

Calculated over the trailing 1-year period

41.02%

24.32%

+16.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.26%

29.32%

+7.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.02%

28.77%

+5.25%

Dividends

BIO vs. DIS - Dividend Comparison

BIO has not paid dividends to shareholders, while DIS's dividend yield for the trailing twelve months is around 1.26%.


PositionTTM20252024202320222021202020192018201720162015
BIO
Bio-Rad Laboratories, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DIS
The Walt Disney Company
1.26%1.10%0.85%0.33%0.00%0.00%0.00%1.22%1.57%1.51%1.43%1.30%

Financials

BIO vs. DIS - Financials Comparison

This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and The Walt Disney Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20222023202420252026
592.10M
25.17B
(BIO) Total Revenue
(DIS) Total Revenue
Values in USD except per share items

BIO vs. DIS - Profitability Comparison

The chart below illustrates the profitability comparison between Bio-Rad Laboratories, Inc. and The Walt Disney Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%35.0%40.0%45.0%50.0%55.0%60.0%20222023202420252026
52.3%
36.8%
Portfolio components
BIO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bio-Rad Laboratories, Inc. reported a gross profit of 309.40M and revenue of 592.10M. Therefore, the gross margin over that period was 52.3%.

DIS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Walt Disney Company reported a gross profit of 9.27B and revenue of 25.17B. Therefore, the gross margin over that period was 36.8%.

BIO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bio-Rad Laboratories, Inc. reported an operating income of 34.10M and revenue of 592.10M, resulting in an operating margin of 5.8%.

DIS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Walt Disney Company reported an operating income of 4.96B and revenue of 25.17B, resulting in an operating margin of 19.7%.

BIO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bio-Rad Laboratories, Inc. reported a net income of -527.10M and revenue of 592.10M, resulting in a net margin of -89.0%.

DIS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Walt Disney Company reported a net income of 2.25B and revenue of 25.17B, resulting in a net margin of 8.9%.


Frequently Asked Questions


BIO and DIS have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BIO has higher volatility (15.46%) compared to DIS (9.87%). In terms of maximum drawdown, BIO dropped -83.64% vs DIS's -85.66%.

BIO currently has the higher Sharpe Ratio (0.94 vs -0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BIO and DIS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer